Swami, Srilatha

Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. [electronic resource] - International journal of cancer May 2009 - 2050-9 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1097-0215

10.1002/ijc.24161 doi


Anticarcinogenic Agents--pharmacology
Biomarkers, Tumor--genetics
Blotting, Western
Cell Proliferation--drug effects
Cells, Cultured
Cyclin-Dependent Kinase Inhibitor p21--genetics
Cyclooxygenase 2--genetics
Dinoprostone--metabolism
Double-Blind Method
Gene Expression Regulation, Neoplastic--drug effects
Genistein--pharmacology
Humans
Hydroxyprostaglandin Dehydrogenases--genetics
Isoflavones--pharmacology
Luciferases--metabolism
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Neoplasms, Hormone-Dependent--drug therapy
Pilot Projects
Promoter Regions, Genetic
Prostatectomy
Prostatic Neoplasms--drug therapy
RNA, Messenger--genetics
Receptors, Prostaglandin--genetics
Signal Transduction
Soy Foods
Transfection